Molecular Therapy - Nucleic Acids
Journal Title
- Molecular Therapy - Nucleic Acids
ISSN
- P 2162-2531
Publisher
- Nature Publishing Group
Listed on(Coverage)
| JCR | 2014-2023 |
|---|---|
| SJR | 2013-2020;2022-2023 |
| CiteScore | 2012-2023 |
| SCIE | 2014-2024 |
| SCOPUS | 2017-2024 |
| DOAJ | 2017-2024 |
| EMBASE | 2016-2024 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | vector development, rna based therapeutics, gene modifying agents |
| Review Process | Anonymous peer review |
| Journal info. pages | |
| Licences | CC BY, CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Therapeutics. Pharmacology |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- USA
Aime & Scopes
- Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048. Other key topics include: /// Applications of DNA-based oligonucleotides and their derivatives /// Gene vectors for delivery of RNA-based therapies /// Development of nanoparticles and other delivery agents /// siRNAs, shRNAs, and miRNAs /// Aptamers, ribozymes, and DNAzymes /// Peptide nucleic acids /// Gene-modifying approaches including enzymes, triplex-forming nucleic acids, and other approaches /// Development of new nucleic acid chemistries for altering gene expression /// Mechanisms of gene and nucleic acid transfer/transfection /// Vector trafficking and biodistribution